Congress funds $2B pediatric cancer push, removes trial cost barriers
H.R. 11039 — Ahmad Butler Pediatric Cancer Hope for a Cure Act · Filed by Brendan Boyle (D-PA) · Introduced Nov 17, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill expands federal investment in pediatric cancer research by $2 billion over 10 years, establishes grants to help families afford clinical trial participation, funds research into holistic therapies, and creates a voluntary donation fund (One Lunch 4 Cure) to supplement research efforts. Families with children battling cancer, researchers, and underserved communities gain access to trials and financial support; the bill also mandates annual public reporting on how federal pediatric cancer dollars are spent.
Why we flagged it
The bill's core mechanism is a $2 billion appropriation for pediatric cancer research, clinical trial access grants, and a voluntary donation fund. It is straightforward public health legislation with no hidden deregulation, liability shields, or narrow private carve-outs.
What the text implies
- The One Lunch 4 Cure Fund's voluntary donation mechanism (including tax-return designations) may generate modest supplemental revenue but creates administrative overhead for IRS and Treasury to track and transfer small individual contributions, potentially exceeding the value of donations collected.
- Section 5's mandate to study 'holistic, integrative, nutritional, and alternative therapies' may fund research into unproven treatments; the bill requires 'evidence-based' evaluation but does not define the evidentiary standard or prevent preliminary funding of low-probability interventions.
- Clinical trial access grants (section 6) may be claimed by entities conducting trials in underserved regions, creating potential for grant capture by well-resourced research institutions that establish satellite trial sites rather than funding trials in genuinely remote or low-income areas.
- The bill's 10-year appropriation ($2B) is front-loaded into the authorization but does not guarantee annual funding; Congress may appropriate less in later fiscal years, creating a cliff effect after 2036 unless reauthorized.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Ordinary families with children facing cancer gain direct financial support for trial participation, expanded access to cutting-edge research regardless of income or location, and public accountability for how federal dollars are spent. Children from minority, rural, and low-income communities are explicitly targeted for equity initiatives. The bill protects existing pediatric cancer programs and dedicates funds solely to pediatric research, preventing reallocation to adult programs.
Who stands to gain
- pediatric cancer research institutions
- children's hospitals
- clinical trial-conducting entities
- National Institutes of Health
- National Cancer Institute
Named in the bill
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Department of the Treasury, Government Accountability Office, One Lunch 4 Cure National Pediatric Cancer Contribution Fund
Where it stands
- Nov 17, 2026 — Introduced · Congress.gov: “Introduced in House”
- Nov 17, 2026 — Referred to House Committee on Ways and Means and House Committee on the Budget · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Budget, and Ways…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (8,131 characters) on Nov 19, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-11-22.
“Congress funds $2B pediatric cancer push, removes trial cost barriers” QuorumCivic. https://share.quorumcivic.app/bill/119/hr11039 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.